244 related articles for article (PubMed ID: 27081859)
1. Broadly-Reactive Neutralizing and Non-neutralizing Antibodies Directed against the H7 Influenza Virus Hemagglutinin Reveal Divergent Mechanisms of Protection.
Tan GS; Leon PE; Albrecht RA; Margine I; Hirsh A; Bahl J; Krammer F
PLoS Pathog; 2016 Apr; 12(4):e1005578. PubMed ID: 27081859
[TBL] [Abstract][Full Text] [Related]
2. Both Neutralizing and Non-Neutralizing Human H7N9 Influenza Vaccine-Induced Monoclonal Antibodies Confer Protection.
Henry Dunand CJ; Leon PE; Huang M; Choi A; Chromikova V; Ho IY; Tan GS; Cruz J; Hirsh A; Zheng NY; Mullarkey CE; Ennis FA; Terajima M; Treanor JJ; Topham DJ; Subbarao K; Palese P; Krammer F; Wilson PC
Cell Host Microbe; 2016 Jun; 19(6):800-13. PubMed ID: 27281570
[TBL] [Abstract][Full Text] [Related]
3. Divergent H7 immunogens offer protection from H7N9 virus challenge.
Krammer F; Albrecht RA; Tan GS; Margine I; Hai R; Schmolke M; Runstadler J; Andrews SF; Wilson PC; Cox RJ; Treanor JJ; García-Sastre A; Palese P
J Virol; 2014 Apr; 88(8):3976-85. PubMed ID: 24453375
[TBL] [Abstract][Full Text] [Related]
4. Human neutralizing antibodies target a conserved lateral patch on H7N9 hemagglutinin head.
Jia M; Zhao H; Morano NC; Lu H; Lui YM; Du H; Becker JE; Yuen KY; Ho DD; Kwong PD; Shapiro L; To KK; Wu X
Nat Commun; 2024 May; 15(1):4505. PubMed ID: 38802413
[TBL] [Abstract][Full Text] [Related]
5. Structural Insight into a Human Neutralizing Antibody against Influenza Virus H7N9.
Chen C; Liu L; Xiao Y; Cui S; Wang J; Jin Q
J Virol; 2018 Mar; 92(5):. PubMed ID: 29212936
[TBL] [Abstract][Full Text] [Related]
6. Preparation and characterization of mouse-derived monoclonal antibodies against the hemagglutinin of the H1N1 influenza virus.
Lin X; Yang F; Yan S; Wu H; Wang P; Zhao Y; Shi D; Yao H; Wu H; Li L
Virus Res; 2024 Jul; 345():199402. PubMed ID: 38772446
[TBL] [Abstract][Full Text] [Related]
7. Cross-reactive antibodies binding to H4 hemagglutinin protect against a lethal H4N6 influenza virus challenge in the mouse model.
Amanat F; Meade P; Strohmeier S; Krammer F
Emerg Microbes Infect; 2019; 8(1):155-168. PubMed ID: 30866770
[TBL] [Abstract][Full Text] [Related]
8. One Against All: A Broadly Influenza Neutralizing Man-made Monoclonal Antibody Passes Phase I.
Saelens X
EBioMedicine; 2016 Mar; 5():16-7. PubMed ID: 27077102
[No Abstract] [Full Text] [Related]
9. Broadly neutralizing hemagglutinin stalk-specific antibodies require FcγR interactions for protection against influenza virus in vivo.
DiLillo DJ; Tan GS; Palese P; Ravetch JV
Nat Med; 2014 Feb; 20(2):143-51. PubMed ID: 24412922
[TBL] [Abstract][Full Text] [Related]
10. H7N9 Live Attenuated Influenza Vaccine Is Highly Immunogenic, Prevents Virus Replication, and Protects Against Severe Bronchopneumonia in Ferrets.
de Jonge J; Isakova-Sivak I; van Dijken H; Spijkers S; Mouthaan J; de Jong R; Smolonogina T; Roholl P; Rudenko L
Mol Ther; 2016 May; 24(5):991-1002. PubMed ID: 26796670
[TBL] [Abstract][Full Text] [Related]
11. Diversity of the murine antibody response targeting influenza A(H1N1pdm09) hemagglutinin.
Wilson JR; Tzeng WP; Spesock A; Music N; Guo Z; Barrington R; Stevens J; Donis RO; Katz JM; York IA
Virology; 2014 Jun; 458-459():114-24. PubMed ID: 24928044
[TBL] [Abstract][Full Text] [Related]
12. Co-immunization with hemagglutinin stem immunogens elicits cross-group neutralizing antibodies and broad protection against influenza A viruses.
Moin SM; Boyington JC; Boyoglu-Barnum S; Gillespie RA; Cerutti G; Cheung CS; Cagigi A; Gallagher JR; Brand J; Prabhakaran M; Tsybovsky Y; Stephens T; Fisher BE; Creanga A; Ataca S; Rawi R; Corbett KS; Crank MC; Karlsson Hedestam GB; Gorman J; McDermott AB; Harris AK; Zhou T; Kwong PD; Shapiro L; Mascola JR; Graham BS; Kanekiyo M
Immunity; 2022 Dec; 55(12):2405-2418.e7. PubMed ID: 36356572
[TBL] [Abstract][Full Text] [Related]
13. Hemagglutination Inhibition (HAI) antibody landscapes after vaccination with H7Nx virus like particles.
Jang H; Ross TM
PLoS One; 2021; 16(3):e0246613. PubMed ID: 33735274
[TBL] [Abstract][Full Text] [Related]
14. Broadly neutralizing influenza hemagglutinin stem-specific antibody CR8020 targets residues that are prone to escape due to host selection pressure.
Tharakaraman K; Subramanian V; Cain D; Sasisekharan V; Sasisekharan R
Cell Host Microbe; 2014 May; 15(5):644-51. PubMed ID: 24832457
[TBL] [Abstract][Full Text] [Related]
15. A comprehensive influenza reporter virus panel for high-throughput deep profiling of neutralizing antibodies.
Creanga A; Gillespie RA; Fisher BE; Andrews SF; Lederhofer J; Yap C; Hatch L; Stephens T; Tsybovsky Y; Crank MC; Ledgerwood JE; McDermott AB; Mascola JR; Graham BS; Kanekiyo M
Nat Commun; 2021 Mar; 12(1):1722. PubMed ID: 33741916
[TBL] [Abstract][Full Text] [Related]
16. Generation and characterization of a nanobody against the avian influenza virus H7 subtype.
Huang X; Li W; Cao X; Zhang Q; Lin Y; Xu S; Dong X; Liu P; Liu Y; He G; Luo K; Feng S
Int J Biol Macromol; 2024 May; 267(Pt 2):131458. PubMed ID: 38593899
[TBL] [Abstract][Full Text] [Related]
17. Anti-influenza H7 human antibody targets antigenic site in hemagglutinin head domain interface.
Dong J; Gilchuk I; Li S; Irving R; Goff MT; Turner HL; Ward AB; Carnahan RH; Crowe JE
J Clin Invest; 2020 Sep; 130(9):4734-4739. PubMed ID: 32749241
[TBL] [Abstract][Full Text] [Related]
18. Eliciting a single amino acid change by vaccination generates antibody protection against group 1 and group 2 influenza A viruses.
Ray R; Nait Mohamed FA; Maurer DP; Huang J; Alpay BA; Ronsard L; Xie Z; Han J; Fernandez-Quintero M; Phan QA; Ursin RL; Vu M; Kirsch KH; Prum T; Rosado VC; Bracamonte-Moreno T; Okonkwo V; Bals J; McCarthy C; Nair U; Kanekiyo M; Ward AB; Schmidt AG; Batista FD; Lingwood D
Immunity; 2024 May; 57(5):1141-1159.e11. PubMed ID: 38670113
[TBL] [Abstract][Full Text] [Related]
19. Vaccination with Consensus H7 Elicits Broadly Reactive and Protective Antibodies against Eurasian and North American Lineage H7 Viruses.
Fadlallah GM; Ma F; Zhang Z; Hao M; Hu J; Li M; Liu H; Liang B; Yao Y; Gong R; Zhang B; Liu D; Chen J
Vaccines (Basel); 2020 Mar; 8(1):. PubMed ID: 32210092
[TBL] [Abstract][Full Text] [Related]
20. Antigenic commonality and divergence of hemagglutinin-esterase-fusion protein among influenza D virus lineages revealed using epitope mapping.
Katayama M; Murakami S; Ishida H; Matsugo H; Sekine W; Ohira K; Takenaka-Uema A; Horimoto T
J Virol; 2024 Mar; 98(3):e0190823. PubMed ID: 38345383
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
